News & Videos - EDWARDS LIFESCIENCES - English

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2024. Highlights and Outlook Q4 sales grew 9% to $1.39 billion 1 , better than expected, with strength across all product groups Q4 TAVR sales grew 6%; constant currency 2 sales grew 5% Q4 TMTT sales grew 88% to $105 million with increasing contribution to Edwards' growth Q4 EPS of $0.58 1 ; adjusted 2 EPS of $0.59, driven by strong top-line performance Presented results of two...

EDWARDS LIFESCIENCES INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW PR Newswire NEW ORLEANS, Feb. 7, 2025 NEW ORLEANS , Feb. 7, 2025 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Edwards Lifesciences Corporation ("the Company")...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Edwards Lifesciences Corporation (“the Company”) (NYSE: EW). On July 24, 2024, the Company announced its financial results for the second quarter of the Fiscal Year ended December 31, 2024 disclosing disappointing results, specifically that the Company slashed its full-year revenue guidance for the...

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended December 31, 2024 after the market closes on Tuesday February 11, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the “Investor Relations” section of the Edwards website at ir.edwards.com . About Edwards Lifesciences Edwards...

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Edwards Lifesciences Corporation (“the Company”) (NYSE: EW). On July 24, 2024, the Company announced its financial results for the second quarter of the Fiscal Year ended December 31, 2024 disclosing disappointing results, specifically that the Company slashed its full-year revenue guidance for the...

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/ , with an archived version accessible later the same...

Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW PR Newswire NEW YORK, Dec. 13, 2024 NEW YORK , Dec. 13, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely...

Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation (“Edwards” or the “Company”) (NYSE: EW) and reminds investors of the December 13, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered...

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Edwards Lifesciences Corporation (“Edwards Lifesciences” or the “Company”) (NYSE: EW ) securities between February 6, 2024 and July 24, 2024 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On July 24, 2024, Edwards Lifesciences announced...

Faruqi & Faruqi Reminds Edwards Lifesciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 - EW PR Newswire NEW YORK, Dec. 12, 2024 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss...

Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW PR Newswire NEW YORK, Dec. 12, 2024 NEW YORK , Dec. 12, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff...

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., Dec. 11, 2024 BENSALEM, Pa. , Dec. 11, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or the "Company") (NYSE: EW ). Class Period: February 6, 2024 – July 24, 2024 Lead Plaintiff Deadline:...

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024. Edwards describes itself as an “international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.” For more information, submit a form ,...

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit PR Newswire NEW YORK, Dec. 10, 2024 NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024 , both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards...

EW Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Edwards Lifesciences Corporation (EW) Investors of Filing Deadline in Class Action Lawsuit PR Newswire RADNOR, Pa., Dec. 10, 2024 RADNOR, Pa. , Dec. 10, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation ("Edwards") (NYSE: EW) on behalf of investors who purchased or otherwise...

Levi & Korsinsky Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline PR Newswire NEW YORK, Dec. 10, 2024 NEW YORK , Dec. 10, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged securities...

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm PR Newswire LOS ANGELES, Dec. 9, 2024 LOS ANGELES , Dec. 9, 2024 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation ("Edwards Lifesciences" or "the Company") (NYSE: EW ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b...

Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - EW PR Newswire NEW YORK, Dec. 9, 2024 NEW YORK , Dec. 9, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Edwards Lifesciences Corporation (NYSE: EW). Shareholders who purchased shares of EW during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead...

Shareholders that lost money on Edwards Lifesciences Corporation(EW) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PR Newswire NEW YORK, Dec. 6, 2024 NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Edwards Lifesciences Corporation ("Edwards" or the "Company") (NYSE: EW) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Edwards investors who were adversely affected by alleged...

EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit PR Newswire NEW YORK, Dec. 6, 2024 NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6, 2024 and July 24, 2024 , both dates inclusive (the "Class Period"), of the important December 13, 2024 lead plaintiff deadline. So what: If you purchased Edwards securities...